Context Therapeutics Inc. · NASDAQ:CNTX
Blue Owl Capital Holdings LP reported a 5.54% stake in Context Therapeutics Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 14, 2026
Blue Owl Capital Holdings LP reported a 5.54% stake in Context Therapeutics Inc., 5,089,015 shares, as a passive investor on Mar 31, 2026. Filed May 14, 2026 (Schedule 13G/A).
- Stake
- 5.54%
- Shares
- 5,089,015
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Blue Owl Capital Holdings LP | 5.54% | 5,089,015 |
Source
Related
- Context Therapeutics Inc.
- Blue Owl Capital Holdings LP
- Context Therapeutics Inc. shareholders
- Schedule 13G/A · Blue Owl Capital Holdings LP · Aug 12, 2026
- Schedule 13G/A · Blue Owl Capital Holdings LP · Feb 14, 2025
- Schedule 13G/A · Mpm Bioimpact LLC · Aug 14, 2026
- Schedule 13G/A · Octagon Capital Advisors LP · Jul 31, 2026
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026
- Schedule 13G/A · Great Point Partners LLC · May 15, 2026
- Schedule 13G · Octagon Capital Advisors LP · May 14, 2026